Migdal Insurance & Financial Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-375
| Closed | -$12K | – | 520 |
|
|
2022
Q2 | $12K | Sell |
375
-17,376
| -98% | -$556K | ﹤0.01% | 505 |
|
|
2022
Q1 | $815K | Sell |
17,751
-1,341
| -7% | -$61.6K | 0.01% | 196 |
|
|
2021
Q4 | $1.17M | Sell |
19,092
-1,707
| -8% | -$105K | 0.01% | 187 |
|
|
2021
Q3 | $1.55M | Buy |
20,799
+1,243
| +6% | +$92.9K | 0.02% | 189 |
|
|
2021
Q2 | $1.81M | Buy |
19,556
+1,904
| +11% | +$176K | 0.02% | 196 |
|
|
2021
Q1 | $1.57M | Buy |
17,652
+1,608
| +10% | +$143K | 0.02% | 211 |
|
|
2020
Q4 | $1.5M | Buy |
16,044
+151
| +1% | +$14.1K | 0.02% | 164 |
|
|
2020
Q3 | $1.01M | Buy |
15,893
+7,399
| +87% | +$472K | 0.01% | 288 |
|
|
2020
Q2 | $429K | Buy |
8,494
+804
| +10% | +$40.6K | 0.01% | 307 |
|
|
2020
Q1 | $241K | Buy |
7,690
+1,942
| +34% | +$60.9K | 0.01% | 296 |
|
|
2019
Q4 | $193K | Buy |
5,748
+638
| +12% | +$21.4K | ﹤0.01% | 421 |
|
|
2019
Q3 | $150K | Buy |
5,110
+1,735
| +51% | +$50.9K | ﹤0.01% | 506 |
|
|
2019
Q2 | $116K | Buy |
3,375
+1,332
| +65% | +$45.8K | ﹤0.01% | 552 |
|
|
2019
Q1 | $67K | Buy |
+2,043
| New | +$67K | ﹤0.01% | 551 |
|